Alaunos Therapeutics, Inc. (TCRT) stock
TCRTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.72+0.06 (+3.61%)
Close on Nov 18, 2026Market cap $4.37MP/E –Yield –
Alaunos Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Alaunos Therapeutics's total debt was $0 at Dec 31, 2024. For fiscal 2024 it was $0. The highest annual figure on record is $24.12M in fiscal 2021.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $0 | – |
| FY2023 | Dec 31, 2023 | $0 | -100.0% |
| FY2022 | Dec 31, 2022 | $16.77M | -30.5% |
| FY2021 | Dec 31, 2021 | $24.12M | – |
| FY2020 | Dec 31, 2020 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | $0 | – |
| Q1 FY2024 | Mar 31, 2024 | $0 | -100.0% |
| Q4 FY2023 | Dec 31, 2023 | $0 | -100.0% |
| Q3 FY2023 | Sep 30, 2023 | $0 | -100.0% |
| Q2 FY2023 | Jun 30, 2023 | $0 | -100.0% |
| Q1 FY2023 | Mar 31, 2023 | $10.99M | -54.8% |
| Q4 FY2022 | Dec 31, 2022 | $16.77M | -30.5% |
| Q3 FY2022 | Sep 30, 2022 | $22.67M | -6.4% |
| Q2 FY2022 | Jun 30, 2022 | $24.52M | – |
| Q1 FY2022 | Mar 31, 2022 | $24.32M | – |
| Q4 FY2021 | Dec 31, 2021 | $24.12M | – |
| Q3 FY2021 | Sep 30, 2021 | $24.21M | – |
| Q4 FY2020 | Dec 31, 2020 | $0 | – |
See a number that looks wrong?